Search Results - O V Desinova

Refine Results
  1. 1
    Experience in using actovegin for focal scleroderma

    Experience in using actovegin for focal scleroderma by Mayya Nikolaevna Starovoytova, O V Desinova, Maya Nikolayevna Starovoitova, O. V. Desinova

    Published 2011-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Therapy for digital ulcers in patients with systemic scleroderma

    Therapy for digital ulcers in patients with systemic scleroderma by M. N. Starovoitova, O. V. Desinova

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Fibrosing arthropathy in juvenile scleroderma

    Fibrosing arthropathy in juvenile scleroderma by D. A. Dibrov, M. N. Starovoitova, O. V. Desinova

    Published 2021-04-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA

    COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA by M N Starovoitova, O V Desinova, A V Volkov

    Published 2009-06-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Scleroderma systematica concurrent with neoplasm

    Scleroderma systematica concurrent with neoplasm by Maya Nikolayevna Starovoitova, N G Guseva, O V Desinova

    Published 2011-06-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report

    Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report by M. N. Starovoitova, O. V. Desinova, N. G. Guseva

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    THE IMPORTANCE OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN EVALUATING THE EFFICACY OF RITUXIMAB IN PATIENTS WITH INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS

    THE IMPORTANCE OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN EVALUATING THE EFFICACY OF RITUXIMAB IN PATIENTS WITH INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS by O. A. Koneva, O. V. Desinova, L. P. Ananyeva, N. V. Kovaleva

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Differential diagnosis of myopathic syndrome in dermatomyositis/polymyositis and progressive muscular dystrophies (description of a case)

    Differential diagnosis of myopathic syndrome in dermatomyositis/polymyositis and progressive muscular dystrophies (description of a case) by Olga Alekseevna Antelava, M N Starovoitova, O V Desinova, S S Nikitin, E L Nasonov

    Published 2012-12-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Use of the international systemic scleroderma activity index

    Use of the international systemic scleroderma activity index by Maya Nikolayevna Starovoitova, L P Ananyeva, O A Koneva, O V Desinova, N G Guseva

    Published 2013-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA

    ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA by Olga Borisovna Ovsyannikova, L P Ananyeva, O A Koneva, O V Desinova, M N Starovoitova

    Published 2012-12-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Risk factors for low bone mineral density in postmenopausal women with systemic sclerosis

    Risk factors for low bone mineral density in postmenopausal women with systemic sclerosis by A. O. Efremova, N. V. Toroptsova, O. V. Dobrovolskaya, M. N. Starovoitova, O. V. Desinova, O. A. Nikitinskaya

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    CHANGES OF ACTIVITY INDEX AND TOTAL SEVERITY INDEX IN PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE OVER A 5-YEAR FOLLOW-UP PERIOD

    CHANGES OF ACTIVITY INDEX AND TOTAL SEVERITY INDEX IN PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE OVER A 5-YEAR FOLLOW-UP PERIOD by O. B. Ovsyannikova, L. P. Ananyeva, V. N. Lesnyak, O. A. Koneva, M. N. Starovoitova, O. V. Desinova

    Published 2016-07-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Features of systemic sclerosis-rheumatoid arthritis overlap syndrome (SS-RA overlap syndrome)

    Features of systemic sclerosis-rheumatoid arthritis overlap syndrome (SS-RA overlap syndrome) by O. V. Desinova, M. N. Starovoytova, I. A. Guseva, A. A. Novikov, E. N. Alexandrova, N. G. Guseva

    Published 2016-05-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA

    CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA by L P Anan'eva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoytova, O V Desinova, L P Ananyeva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoitova, O V Desinova

    Published 2011-04-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION

    SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION by Lyudmila Valeryevna Teplova, L P Ananyeva, V N Lesnyak, M N Starovoitova, O V Desinova, T A Nevskaya, E N Aleksandrova

    Published 2010-06-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Renal function during long-term therapy with rituximab in patients with systemic sclerosis

    Renal function during long-term therapy with rituximab in patients with systemic sclerosis by M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies

    Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies by R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis

    Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis by M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma

    Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma by R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Relationship between digital ulcers and severity of lung function test in systemic sclerosis over a five-year period

    Relationship between digital ulcers and severity of lung function test in systemic sclerosis over a five-year period by O. B. Ovsyannikova, O. A. Koneva, L. P. Ananieva, L. A. Garzanova, M. N. Srarovoytova, O. V. Desinova, R. U. Shayakhmetova

    Published 2022-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: